{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:04:31Z","timestamp":1790233471415,"version":"4.1.0"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejrad.2026.113108","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:17:29Z","timestamp":1784906249000},"page":"113108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Radiological evaluation of the natural history of PIK3CA-related overgrowth spectrum (PROS)"],"prefix":"10.1016","volume":"204","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4414-1246","authenticated-orcid":false,"given":"Antoine","family":"Fraissenon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8423-6701","authenticated-orcid":false,"given":"Gabriel","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0991-7774","authenticated-orcid":false,"given":"Nathalie","family":"Boddaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klervie","family":"Loiselet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laureline","family":"Berteloot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Guibaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9901-8635","authenticated-orcid":false,"given":"Guillaume","family":"Canaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejrad.2026.113108_b0005","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-genom-121222-114518","article-title":"PIK3CA-related Disorders: from Disease Mechanism to Evidence-based Treatments","author":"Morin","year":"2024","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.ejrad.2026.113108_b0015","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s13023-021-01929-8","article-title":"A review of mechanisms of disease across PIK3CA-related disorders with vascular manifestations","volume":"16","author":"Canaud","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ejrad.2026.113108_b0020","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jvsv.2018.01.015","article-title":"Pulmonary thromboembolic events in patients with congenital lipomatous overgrowth, vascular malformations, epidermal nevi, and spinal\/skeletal abnormalities and Klippel-Trenaunay syndrome","volume":"6","author":"Reis","year":"2018","journal-title":"J. Vasc. Surg. Venous Lymphat. Disord."},{"key":"10.1016\/j.ejrad.2026.113108_b0025","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jtcvs.2010.04.023","article-title":"CLOVES syndrome with thoracic and central phlebectasia: increased risk of pulmonary embolism","volume":"140","author":"Alomari","year":"2010","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ejrad.2026.113108_b0030","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/ajmg.a.36552","article-title":"Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum","volume":"164A","author":"Keppler-Noreuil","year":"2014","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ejrad.2026.113108_b0035","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13023-018-0934-z","article-title":"Sirolimus is efficacious in treatment for extensive and\/or complex slow-flow vascular malformations: a monocentric prospective phase II study","volume":"13","author":"Hammer","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ejrad.2026.113108_b0040","article-title":"Alpelisib for Treatment of patients with PIK3CA-related Overgrowth Spectrum (PROS)","volume":"100969","author":"Canaud","year":"2023","journal-title":"Genet. Med."},{"key":"10.1016\/j.ejrad.2026.113108_b0045","article-title":"PI3K inhibitors are finally coming of age","author":"Vanhaesebroeck","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejrad.2026.113108_b0050","doi-asserted-by":"crossref","unstructured":"Morin, G., Galasso, I. & Canaud, G. Vascular malformations: from genetics to therapeutics. EMBO molecular medicine (2025). https:\/\/doi.org:10.1038\/s44321-025-00344-x.","DOI":"10.1038\/s44321-025-00344-x"},{"key":"10.1016\/j.ejrad.2026.113108_b0055","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41586-018-0217-9","article-title":"Targeted therapy in patients with PIK3CA-related overgrowth syndrome","volume":"558","author":"Venot","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ejrad.2026.113108_b0060","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abg0809","article-title":"Alpelisib administration reduced lymphatic malformations in a mouse model and in patients","volume":"13","author":"Delestre","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejrad.2026.113108_b0065","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20212148","article-title":"Treatment of two infants with PIK3CA-related overgrowth spectrum by alpelisib","volume":"219","author":"Morin","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejrad.2026.113108_b0070","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ade7823","article-title":"PIK3CA gain-of-function mutation in adipose tissue induces metabolic reprogramming with Warburg-like effect and severe endocrine disruption","volume":"8","author":"Ladraa","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejrad.2026.113108_b0075","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","article-title":"RECIST 1.1-Update and clarification: from the RECIST committee","volume":"62","author":"Schwartz","year":"2016","journal-title":"Eur. J. Cancer"}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X26004560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X26004560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:43:09Z","timestamp":1790232189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X26004560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":14,"alternative-id":["S0720048X26004560"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2026.113108","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiological evaluation of the natural history of PIK3CA-related overgrowth spectrum (PROS)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2026.113108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113108"}}